Jimin Han is the Director of ESG at Samsung Biologics, where he oversees ESG strategies, PCF initiatives, renewable energy transition, and responsible sourcing across manufacturing facilities. He has over 15 years of experience at Samsung Biologics, having managed operational risk through business continuity management and embedded ESG considerations into every phase of drug development and production.